Emtricitabine 200 mg and Tenofovir Alafenamide 25 mg Tablets

Get a Price/Quote

MOQ : 100 Packs

Emtricitabine 200 mg and Tenofovir Alafenamide 25 mg Tablets Specification

Salt Composition
Emtricitabine 200 mg + Tenofovir Alafenamide 25 mg

Dosage Form
Film-coated tablet

Indication
HIV-1 infection treatment in adults and adolescents

Enzyme Types
Not applicable (antiviral agents)

Feature
Fixed-dose combination, once daily dosing

Ingredients
Emtricitabine, Tenofovir Alafenamide, Excipients

Application
Antiretroviral therapy for HIV

Physical Color/Texture
Film-coated, blue, capsule-shaped tablet

Storage Instructions
Store below 30C, protect from moisture

Shelf Life
36 months

Special Precautions
Monitor renal function, avoid with strong P-gp inducers

Contraindications
Known hypersensitivity to active substances

Manufactured By
Varies by manufacturer

Tablet Markings
Embossed code on each tablet (varies as per producer)

Route of Administration
Oral

Trade Name
Varies by manufacturer (eg: TAFERO-EM, Descovy, etc.)

Common Side Effects
Headache, nausea, abdominal pain, fatigue

ATC Code
J05AR17

Prescription Status
Prescription only

Bioavailability
High (improved renal and bone safety profile versus TDF)

Packaging
Bottle of 30 tablets

Emtricitabine 200 mg and Tenofovir Alafenamide 25 mg Tablets Trade Information

Minimum Order Quantity
100 Packs

Payment Terms
Cash in Advance (CID)

Supply Ability
5000 Packs Per Month

Delivery Time
10 Days

Main Domestic Market
All India

About Emtricitabine 200 mg and Tenofovir Alafenamide 25 mg Tablets

Grab the unmatchable benefits of Emtricitabine 200 mg and Tenofovir Alafenamide 25 mg Tablets-a must-have in advanced antiretroviral therapy. Designed for unwavering efficacy, these dazzling blue, film-coated tablets offer unassailable protection in HIV-1 infection treatment for adults and adolescents. Available in a bottle of 30 for prescription use, each tablet ensures high bioavailability, improved renal and bone safety, and once-daily convenience. Act now with advance purchase, supported by reliable suppliers and traders in India. Storage is simple: keep below 30C and protect from moisture. Shelf life is 36 months.

Usage and Application: Optimal Antiretroviral Solution

Emtricitabine 200 mg and Tenofovir Alafenamide 25 mg Tablets are primarily used for the treatment of HIV-1 infection in adults and adolescents. They are administered orally, once daily, as a fixed-dose combination to simplify therapy and improve adherence. Commonly employed in hospitals, clinics, and home-based care settings, these tablets offer convenience and confidence in compliant antiretroviral management. Directions: Swallow the film-coated tablet whole, with or without food, following the prescribed regimen by your healthcare provider.

Supply Reliability and Export Markets

Our logistics and transportation partners ensure seamless dispatch of Emtricitabine and Tenofovir Alafenamide Tablets to key export markets like Asia, Africa, and Latin America. With robust supply ability, we offer rapid quotations upon inquiry and facilitate global sample availability for evaluation. Each shipment is meticulously handled to preserve integrity, guaranteeing prompt, secure delivery. Whether you are a supplier or trader, you can depend on our skill in logistics and international order fulfillment for your antiretroviral therapy requirements.

FAQ's of Emtricitabine 200 mg and Tenofovir Alafenamide 25 mg Tablets:

Q: How should Emtricitabine and Tenofovir Alafenamide Tablets be taken for best results?

A: These tablets should be taken orally, once daily, exactly as prescribed by your healthcare professional. Swallow the whole tablet with or without food, and avoid missing doses to maintain their unassailable effectiveness.

Q: What is the main benefit of choosing this fixed-dose combination for HIV therapy?

A: The fixed-dose combination offers high bioavailability with improved renal and bone safety compared to TDF-based alternatives, streamlining therapy and helping patients remain adherent with once-daily dosing.

Q: When should a patient avoid using this product?

A: This medication must not be used in patients with known hypersensitivity to either Emtricitabine or Tenofovir Alafenamide. Use should also be avoided with strong P-gp inducers and in individuals with significant renal impairment, as advised by your doctor.

Q: Where can these tablets be supplied from, and do you provide global delivery?

A: These tablets are widely supplied by manufacturers, traders, and suppliers based in India, with logistics expertise for global export to markets such as Asia, Africa, and Latin America. Efficient transportation ensures timely international delivery.

Q: What is the process to request a sample or quotation for bulk orders?

A: To request a sample or receive a quotation, simply contact our sales or export team. We will promptly coordinate logistics for sample dispatch and provide a comprehensive quotation tailored to your specific requirements.

Q: What precautions should be taken while using these tablets?

A: Regular monitoring of renal function is advised during therapy. Inform your healthcare provider about any concurrent medications, and avoid use with strong P-glycoprotein inducers to ensure safety and effectiveness.

Tell us about your requirement